Company · CIK 1851194
Ventyx Biosciences, Inc.
| CIK | 1851194 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-11-18 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-278584 | 2024-04-09 | 2026-03-06 | 3 | |
| 333-283076 | 2024-11-07 | 2026-03-06 | 3 | |
| 333-268909 | 2022-12-20 | 2024-04-26 | 2 | |
| 333-267626 | 2022-09-27 | 2022-12-22 | 3 | |
| 333-259891 | 2021-09-29 | 2021-10-21 | 5 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-06 | EFFECTDeclared effective | 333-283076 | 9999999995-26-000741 |
| 2026-03-06 | EFFECTDeclared effective | 333-278584 | 9999999995-26-000740 |
| 2024-11-15 | EFFECTDeclared effective | 333-283076 | 9999999995-24-003504 |
| 2024-11-07 | S-3Shelf registered | 333-283076 | 0001193125-24-253293 |
| 2024-04-29 | EFFECTDeclared effective | 333-278584 | 9999999995-24-001185 |
| 2024-04-26 | EFFECTDeclared effective | 333-268909 | 9999999995-24-001142 |
| 2024-04-09 | S-3Shelf registered | 333-278584 | 0001193125-24-090959 |
| 2022-12-22 | EFFECTDeclared effective | 333-267626 | 9999999995-22-003620 |
| 2022-12-20 | S-3ASRShelf registered | 333-268909 | 0001193125-22-309145 |
| 2022-10-04 | EFFECTDeclared effective | 333-267626 | 9999999995-22-002920 |
| 2022-09-27 | S-1Registration filed | 333-267626 | 0001193125-22-251475 |
| 2021-10-21 | 424B4Final prospectus | 333-259891 | 0001193125-21-304165 |
| 2021-10-20 | EFFECTDeclared effective | 333-259891 | 9999999995-21-003965 |
| 2021-10-15 | S-1/AAmendment | 333-259891 | 0001193125-21-299315 |
| 2021-10-14 | S-1/AAmendment | 333-259891 | 0001193125-21-298518 |
| 2021-09-29 | S-1Registration filed | 333-259891 | 0001564590-21-049504 |
| 2021-08-20 | DRSDraft made public | 377-05394 | 0000950123-21-011766 |